Kalmar Investments’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
TCM
O
CCA
RIM
Kalmar Investments's RGEN Position: Q1 2017 in Review
Kalmar Investments reduced its Repligen (RGEN) stake by 47% in Q1 2017, selling an estimated $9.39M and leaving 330,742 shares worth $11.6M. The position accounts for 2.63% of the portfolio, ranked #3.
Kalmar Investments first reported a position in RGEN in Q3 2013 and has held it in 15 quarters since. The position peaked at $20M in Q3 2016. 180 funds tracked by Wall St. Rank hold RGEN as of Q1 2017.
- Kalmar Investments held 330,742 shares of Repligen worth $11.6M as of Q1 2017.
- Kalmar Investments sold 296,664 Repligen shares in Q1 2017, an estimated $9.39M.
- Repligen made up 2.63% of Kalmar Investments's portfolio in Q1 2017, its #3 holding.
- Kalmar Investments first reported a position in Repligen in Q3 2013 and has held it in 15 quarters since.
- Kalmar Investments's Repligen position peaked at $20M in Q3 2016.
- 180 funds tracked by Wall St. Rank held Repligen as of Q1 2017.
Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.